
Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab
- Author
- Kelly Schats, Emily A Van Vre, Isolde Debyser, Arno Vandenbroeck, Yanina Jansen, Teofila Seremet, Koen Marien, Erik Fransen, Dorien Schrijvers, Wim Van Criekinge (UGent) , Kris Thielemans, Bart Neyns, Ingrid De Meester and Mark Kockx
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8557769
- MLA
- Schats, Kelly, et al. “Immune Cell Profiling of Melanoma Metastases from Patients Treated with TriMixDC-MEL Dendritic Cell Therapy in Combination with Ipilimumab.” JOURNAL OF CLINICAL ONCOLOGY, vol. 35, no. suppl. 15, 2017, doi:10.1200/JCO.2017.35.15_suppl.e21030.
- APA
- Schats, K., Van Vre, E. A., Debyser, I., Vandenbroeck, A., Jansen, Y., Seremet, T., … Kockx, M. (2017). Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab. JOURNAL OF CLINICAL ONCOLOGY, 35(suppl. 15). https://doi.org/10.1200/JCO.2017.35.15_suppl.e21030
- Chicago author-date
- Schats, Kelly, Emily A Van Vre, Isolde Debyser, Arno Vandenbroeck, Yanina Jansen, Teofila Seremet, Koen Marien, et al. 2017. “Immune Cell Profiling of Melanoma Metastases from Patients Treated with TriMixDC-MEL Dendritic Cell Therapy in Combination with Ipilimumab.” In JOURNAL OF CLINICAL ONCOLOGY. Vol. 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.e21030.
- Chicago author-date (all authors)
- Schats, Kelly, Emily A Van Vre, Isolde Debyser, Arno Vandenbroeck, Yanina Jansen, Teofila Seremet, Koen Marien, Erik Fransen, Dorien Schrijvers, Wim Van Criekinge, Kris Thielemans, Bart Neyns, Ingrid De Meester, and Mark Kockx. 2017. “Immune Cell Profiling of Melanoma Metastases from Patients Treated with TriMixDC-MEL Dendritic Cell Therapy in Combination with Ipilimumab.” In JOURNAL OF CLINICAL ONCOLOGY. Vol. 35. doi:10.1200/JCO.2017.35.15_suppl.e21030.
- Vancouver
- 1.Schats K, Van Vre EA, Debyser I, Vandenbroeck A, Jansen Y, Seremet T, et al. Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab. In: JOURNAL OF CLINICAL ONCOLOGY. 2017.
- IEEE
- [1]K. Schats et al., “Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab,” in JOURNAL OF CLINICAL ONCOLOGY, Chicago, IL, USA, 2017, vol. 35, no. suppl. 15.
@inproceedings{8557769, articleno = {{abstract e21030}}, author = {{Schats, Kelly and Van Vre, Emily A and Debyser, Isolde and Vandenbroeck, Arno and Jansen, Yanina and Seremet, Teofila and Marien, Koen and Fransen, Erik and Schrijvers, Dorien and Van Criekinge, Wim and Thielemans, Kris and Neyns, Bart and De Meester, Ingrid and Kockx, Mark}}, booktitle = {{JOURNAL OF CLINICAL ONCOLOGY}}, issn = {{0732-183X}}, language = {{eng}}, location = {{Chicago, IL, USA}}, number = {{suppl. 15}}, title = {{Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab}}, url = {{http://doi.org/10.1200/JCO.2017.35.15_suppl.e21030}}, volume = {{35}}, year = {{2017}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: